Moderna (MRNA) to Supply an 20M Doses of COVID-19 Vaccine to COVAX for 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Moderna (MRNA) and Australia Collaborate to Bring mRNA Manufacturing to Australia
December 14, 2021 5:50 AM ESTModerna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an agreement in principle with the Australian Government to build a state-of-the-art messenger RNA (mRNA) vaccine manufacturing facility in Victoria, Australia including access to Modernas mRNA development engine. The contemplated framework would build the foundation to support Australia with direct access to rapid pandemic response capabilities and to provide access to Modernas vaccines in development for respiratory viruses. Moderna and the Australian government are committed to finalize the... More
Moderna's (MRNA) COVID-19 Vaccine Manufactured in Korea by Samsung Granted Marketing Authorization from Ministry of Food and Drug Safety of Korea
December 14, 2021 5:46 AM ESTModerna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced today that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing authorization for Spikevax®, Moderna's COVID-19 vaccine (mRNA-1273) manufactured by Samsung Biologics, a leading global CDMO providing fully integrated end-to-end contract development and manufacturing services.
This marketing authorization obtained by Moderna Korea officially allows the Moderna's COVID-19 vaccine manufactured at Samsung Biologics' local pharmaceutical production facilities to be distributed within Korea and... More
Moderna (MRNA) Continues to Grind off Lows, Remains Down 5.5%
December 10, 2021 12:14 PM ESTModerna (NASDAQ: MRNA) continues to grind off lows, shares remain down 5.5%. A U.K. study that boosters give 70-75% Omicron protection is helping.
... MoreModerna (MRNA) Stock Down 11% on Likely Disappointing Flu Vaccine Data, Seen as 'Undifferentiated' by Morgan Stanley
December 10, 2021 9:51 AM ESTMorgan Stanley analyst Matthew Harrison briefly weighed in on the preliminary flu vaccine data released by Moderna (NASDAQ: MRNA) this morning.
Modernas mRNA-1010 vaccine candidate successfully boosted hemagglutination inhibition (HAI) assay geometric mean titers against all strains 29 days after vaccination at all doses tested in both younger and older adults, the company said in a press... More
